Stephen K. Brannan Insider Profile
4 Followers
Stephen K. Brannan, Director at Serina Therapeutics, holds 1.00K shares in Serina Therapeutics (Ticker: SER), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX). Most recently, Stephen K. Brannan Bought ― shares of Serina Therapeutics on Jul 09, 2026 for an estimated value of $2.03K.
Stephen K. Brannan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephen K. Brannan's holdings
Insider Roles
Director
Roles that Stephen K. Brannan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stephen K. Brannan
Stephen K. Brannan's Trading History
Serina Therapeutics
Jul 09, 2026
Director
Informative Buy
2.03K
$2.73K
Karuna Therapeutics
Mar 18, 2024
―
Uninformative Sell
14.06M
$0.00
List of latest transactions for each holding click on a transaction to see Stephen K. Brannan's performance on stock
You May Also Like
Stephen K. Brannan insider profile FAQ
What is the percentage of profitable transactions made by Stephen K. Brannan?
The percentage of profitable transactions made by Stephen K. Brannan is ―.
What is the average return per transaction made by Stephen K. Brannan?
The average return per transaction made by Stephen K. Brannan is ―.
What stocks does Stephen K. Brannan hold?
Stephen K. Brannan holds: SER, KRTX stocks.
What was Stephen K. Brannan’s latest transaction?
Stephen K. Brannan latest transaction was an Informative Buy of $2.03K.
What was Stephen K. Brannan's most profitable transaction?
Stephen K. Brannan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stephen K. Brannan's role in Serina Therapeutics?
Stephen K. Brannan's role in Serina Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.